Clasado’s Bimuno GOS approved by Health Canada with 10 authorized health claims
The ingredient has already garnered regulatory nods ranging from self-substantiated claims under Food Standards Australia New Zealand, approval from the Food & Drug Administration Philippines, and structure-function claims in the U.S.
Photo © iStockphoto.com
Health Canada has approved Clasado Biosciences’ (Berkshire, UK) Bimuno GOS galactooligosaccharides prebiotic ingredient for use in Natural Health Products (NHPs). The regulator approved 10 health claims that can now be used on products featuring Bimuno GOS.
The ingredient has already garnered regulatory nods ranging from self-substantiated claims under Food Standards Australia New Zealand, approval from the Food & Drug Administration Philippines, and structure-function claims in the U.S.
In Canada, the 10 health claims that can be used on packaging for products containing Bimuno GOS are:
- A source of prebiotic fiber
- Helps support and maintain a healthy digestive system
- Helps support and/or maintain a healthy digestive system in just seven days
- Helps support intestinal/gastrointestinal health
- Helps support healthy gastrointestinal function
- (Clinically shown to help)/helps to relieve digestive symptoms such as abdominal discomfort, gas, and bloating in healthy adults
- (Clinically shown to help)/ helps increase levels of healthy gastrointestinal bacteria, such as Bifidobacteria
- Helps (to) reduce the risk of traveler’s diarrhea
- Helps maintain immune health
- Helps to reduce blood C-reactive protein levels, a clinical marker of inflammation
In a press release, Lucie Nagy, general counsel, Clasado Biosciences, said that “the approval highlights some of the key areas of efficacy for Bimuno GOS, including its influence on gastrointestinal health and immunity.”
What's next for NPA and CRN in their complaints against New York state?
May 2nd 2024The latest updates in the efforts of the Natural Products Association and the Council for Responsible Nutrition to sue New York state for its law banning the sale of weight management and muscle building supplements to minors.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
